Login

PSMA PET CT Before Lutetium-177 PSMA Therapy

PSMA PET CT Before Lutetium-177 PSMA Therapy

Lutetium-177 PSMA therapy treats advanced prostate cancer, and a PSMA PET CT decides who is suitable. Learn how the scan is used, what makes a patient eligible and what to expect.

Lutetium-177 PSMA therapy is a targeted radioligand treatment for advanced prostate cancer that has stopped responding to hormone therapy and chemotherapy. The treatment carries radiation directly to PSMA-positive cancer cells. Before treatment, a PSMA PET CT is essential to show that the cancer cells strongly carry PSMA and that there is no large PSMA-negative disease, because the drug would not work on those.

What Is Lutetium-177 PSMA Therapy?

A PSMA-binding molecule carries a radioactive atom (Lutetium-177) that emits beta radiation over a short distance. The drug is given by injection into a vein in a nuclear medicine ward, in about 4 to 6 cycles, every 6 weeks. It damages PSMA-positive cancer cells and spares most normal tissue. It is used in metastatic castration-resistant prostate cancer after hormone and chemotherapy treatment, according to guidelines and trial results. See PSMA PET CT.

Pre-treatment questionRole of the scanAre the cancer deposits PSMA-positive?PSMA PET CT shows uptake in lesionsIs there significant PSMA-negative disease?FDG PET CT or CT may show lesions without PSMA uptakeAre kidneys and bone marrow fit?Blood tests, kidney scan and countsHow much disease is present?Baseline for response checksResponse after cycles?Repeat PSMA PET CT and PSA

Why PSMA PET CT Is Needed First

The treatment works only if the tumour has enough PSMA. The PET CT shows the amount of uptake in each lesion, compared with liver uptake. Patients whose lesions are mostly bright qualify. If some lesions show no PSMA uptake but are active on FDG PET CT or visible on CT, they may not respond. See FDG PET for follow-up and PSMA PET CT report explained.

Other Tests Before Treatment

  • Blood counts, kidney and liver function, PSA
  • Sometimes a kidney scan to check filtration
  • CT or bone scan for disease extent
  • Review by a multidisciplinary team

Possible Side Effects

Common effects include dry mouth (salivary gland uptake), tiredness, nausea, low blood counts and, less often, kidney effects. Most are mild to moderate and manageable. Radiation safety rules apply for a few days after each cycle, such as keeping distance from family members and using separate toilets. Your team will explain the precautions in detail.

Response Assessment

PSA is checked regularly, and a repeat PSMA PET CT after a few cycles shows response. Falling PSA and shrinking lesions suggest benefit. If the disease is not responding, other options are discussed. Treatment decisions are individual, based on trial evidence and your health. See PSMA PET CT after surgery.

A Practical Example

Surinder, 70, has metastatic prostate cancer that has progressed after hormone therapy and chemotherapy. A PSMA PET CT shows intense uptake in all lesions, and FDG PET shows no extra PSMA-negative disease. He starts Lutetium-177 therapy, and after three cycles, his PSA falls by more than half, and his bone pain improves.

Key Facts at a Glance

  • PSMA PET CT decides who can have Lutetium-177 therapy
  • Treatment needs PSMA-positive disease
  • Side effects include dry mouth and low blood counts
  • Radiation safety rules apply after each cycle

After the Scan and Next Steps

Discuss with a nuclear medicine physician and a medical oncologist whether you are suitable and where therapy is available, since only some centres offer it. Keep up your PSA tests, report bone pain, bleeding or infection signs early and follow all radiation safety instructions. Palliative and supportive care help with pain and quality of life.

Questions to Ask Your Doctor

  • Is my disease PSMA-positive enough for treatment?
  • Do I need an FDG PET CT too?
  • Are my kidneys and bone marrow suitable?
  • What precautions will my family need to follow after each cycle?

Common Mistakes to Avoid

  • Ignoring radiation safety instructions after treatment.
  • Expecting the treatment to work for PSMA-negative disease.
  • Skipping blood tests between cycles.

Booking, Timing and Report

Ask your doctor for the best timing of the scan. Book a morning slot so that fasting is easier, arrange someone to accompany you, and allow 2 to 3 hours at the centre. Carry biopsy, scan and blood reports and a medicine list. Reports are usually ready within 24 to 48 hours, and images can be given on a CD or digital link for your doctor.

Frequently Asked Questions

What is Lutetium-177 PSMA therapy?

A radioactive drug that targets PSMA-positive prostate cancer cells.

Who can have it?

People with advanced PSMA-positive prostate cancer, as per guidelines.

Why is PSMA PET CT needed first?

To confirm the tumour carries PSMA.

Is FDG PET CT also needed?

Often, to look for PSMA-negative disease.

What are the side effects?

Dry mouth, tiredness, nausea and low blood counts.

How many cycles are given?

Often up to 6.

Is it painful?

No, it is given by drip.

Is it available everywhere?

No, only in some centres.

When is the scan report ready?

Usually 24 to 48 hours.

Book Your Test at Ganesh Diagnostic

Ganesh Diagnostic & Imaging Centre in Rohini, Delhi offers this test with trained nuclear medicine and radiology staff and clear reports. You can book an appointment online, check our branches across Delhi NCR, contact us for current rates, or explore all our services. Reports can be downloaded online through our patient portal, so you do not need to make a second trip just to collect them.

This article is for general information only. It does not replace advice from your doctor. Always follow your doctor's instructions for your test.

Related Reading